Status:
RECRUITING
Ketamine Treatment Plans for Chronic Conditions
Lead Sponsor:
RIVER Foundation
Conditions:
Chronic Pain
Depressive Disorder
Eligibility:
All Genders
18+ years
Brief Summary
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic con...
Detailed Description
Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearp...
Eligibility Criteria
Inclusion
- Must have an identifiable chronic condition.
Exclusion
- Healthy population
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06038409
Start Date
January 1 2023
End Date
June 1 2029
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RIVER Telehealth
Helena, Montana, United States, 59601